Condition : Rheumatoid Arthritis Interventions : Drug: BMS-945429 Placebo; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Drug: Methotrexate; Drug: Met...

Condition : Rheumatoid Arthritis Interventions : Drug: BMS-945429 Placebo; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Drug: Methotrexate; Drug: Met...

Condition : Moderate to Severe Plaque-type Psoriasis Interventions : Drug: secukinumab 150 mg; Drug: secukinumab 150 mg; Drug: placebo to secukinumab 150 mg Sponsor : Novartis Pharmaceuticals Recruiti...

Condition : Moderate to Severe Plaque-type Psoriasis Interventions : Drug: secukinumab 150 mg; Drug: secukinumab 150 mg; Drug: placebo to secukinumab 150 mg Sponsor : Novartis Pharmaceuticals Recruiti...

Conditions : Rheumatoid Arthritis; Inflammation Interventions : Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo Sponsor : Novo...

Conditions : Rheumatoid Arthritis; Inflammation Interventions : Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo; Drug: NNC 0141-0000-0100; Drug: placebo Sponsor : Novo...

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified February 2014

Conditions : Uveitis; Juvenile Arthritis Interventions : Drug: Anti-tumor necrosis factor alpha monoclonal antibody; Drug: placebo Sponsors : Assistance Publique - Hôpitaux de Paris; Assistance Publiq...